The global bowel management systems market is projected to grow at a CAGR of 4.13% to reach US$1,077.824 million by 2029, from US$811.927 million in 2022.
The bowel management system consists of medical gadgets, procedures, and interventions to assist individuals with impaired bowel control. This includes those with neurological clutter, such as neurogenic bowel dysfunction, spinal cord-related injuries, and numerous types of sclerosis. The main goal of these systems is to observe, analyze, and monitor the movement of the bowel, avoid fecal incontinence or stoppage, and upgrade the quality of life for these people. These systems may incorporate dietary adjustments, medicines, and the utilization of therapeutic gadgets such as rectal suppositories, bowel purges, or bowel irrigation systems.
The worldwide bowel management systems industry incorporates the manufacturing, distribution, and sales of items and solutions outlined to address bowel dysfunction and progress bowel management. Variables contributing to this market expansion are primarily the predominance of neurological clutter, the growing senior-age populace, innovative technological advancements, a patient-centric approach, and rising healthcare use.
Neurological disorders, like spinal cord injuries, different sclerosis, and certain neurological clutters, can result in bowel brokenness, driving the request for bowel administration arrangements. Technological progressions offer moved forward viability, consolation, and comfort for people overseeing bowel dysfunction in their daily lives.
Global Bowel Management System Market Drivers:
The bowel management system helps patients maintain clean, uncontaminated skin by treating fecal irregularity. The device is a soft catheter inserted into the rectum to contain and divert fecal waste—the surge in availability of technologically advanced devices for fecal management and the rise in the geriatric population.
The increase in fecal inconsistency-related disorders is the major factor driving the market for bowel management systems. Furthermore, increased awareness of the availability of these devices, combined with the introduction of new devices that address many unserved needs, contributes to the bowel management system market's growth.
According to the AANP data of April 2024, Irritable bowel syndrome (IBS), a chronic gastrointestinal condition affecting 25 to 45 million people in the US, can limit their ability to work, attend school, and maintain relationships. Despite affecting 5 to 10% of the global population, 75% of those with IBS may be undiagnosed. Patients seeking medical treatment may wait up to four years before seeing their healthcare provider. Furthermore, favourable reimbursement scenarios in developed economies and technological advancements in bowel management systems drive market growth.
As individuals age, cognitive function declines, and alertness and control over bloody functions decrease, which is one reason geriatric individuals require assistance. Fecal irregularity, especially within the aging population, may be a developing concern driving the request for bowel administration frameworks. Components contributing to this involve the global maturing populace and persistent conditions such as neurological diseases, diabetes, and certain gastrointestinal illnesses, which can cause bowel irregularity.
Additionally, post-surgical and medical treatments can lead to temporary or chronic bowel dysfunction, making it crucial for individuals to manage these issues effectively. The bowel management systems market is expected to grow due to these factors and the need to address the growing problem of fecal inconsistency in the aging population. A large number of adults have fecal incontinence, which is fueling up the requirement for bowel management frameworks.
There is an increment within the utilization of colostomy bags as the number of people enduring illnesses and complications related to the bowel is expanding. In expansion, infections like irritable bowel disorder are more common among the aging population. According to the Centers for Disease Control and Prevention data of April 2022, IBD, including Crohn's disease and ulcerative colitis, affects 1.3% of the US adult population, including 3.1 million adults.
Global Bowel Management System Market Geographical Outlook
The North American region is evaluated to increase essentially in industry share over the projected period owing to the increasing number of severe infections, well-positioned healthcare systems, and well-developed healthcare framework. Moreover, the increasing awareness among patients regarding the hazards of different bowel issues is additionally anticipated to contribute to this region's market expansion.
Due to an increment in the number of severe illnesses like intestinal cancer and colorectal cancer among the populace, the North American countries are anticipated to hold moderate market size and contribute to its expansion over the estimated period. As a result, the chance of bowel diseases influencing the geriatric population is expanding.
Global Bowel Management System Market Key Developments:
Global Bowel Management System Market Players and Products:
| Report Metric | Details |
|---|---|
| Study Period | 2021 to 2031 |
| Historical Data | 2021 to 2024 |
| Base Year | 2025 |
| Forecast Period | 2026 – 2031 |
| Report Metric | Details |
| Market Size Value in 2022 | US$811.927 million |
| Market Size Value in 2029 | US$1,077.824 million |
| Growth Rate | CAGR of 4.13% from 2022 to 2029 |
| Study Period | 2019 to 2029 |
| Historical Data | 2019 to 2022 |
| Base Year | 2023 |
| Forecast Period | 2024 – 2029 |
| Forecast Unit (Value) | USD Million |
| Segments Covered |
|
| Companies Covered | |
| Regions Covered | North America, South America, Europe, Middle East and Africa, Asia Pacific |
| Customization Scope | Free report customization with purchase |
Market Segmentation:
Global Bowel Management Systems Market is segmented and analyzed as below: